A selective approach based on “gatekeeper” stress testing to find older non-ST segment elevation (NSTEMI) patients most likely to benefit from invasive management fails to prove noninferior to routine angiography for 1-year major adverse cardiac and cerebrovascular events (MACCE), investigators in the EVAOLD study say.